Literature DB >> 1572656

Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2.

M H Grossman1, B S Emanuel, M L Budarf.   

Abstract

Catechol-O-methyltransferase (COMT; EC 2.1.1.6) is a physiologically important enzyme in the metabolism of catecholamine neurotransmitters and catechol drugs. Using primers derived from the known rat cDNA sequence for COMT, we have used the polymerase chain reaction to produce an amplified DNA fragment corresponding to the complete coding region of the rat gene. With this fragment as a probe, we have hybridized DNAs from two panels consisting of human/rodent and human/hamster somatic cell hybrids carrying various translocations and deletions to refine the chromosomal location of human COMT. Southern blot analysis indicates that the human COMT gene is localized to 22q11.1----q11.2, a region to which several anonymous DNA sequences, but until now, no structural genes, have been assigned.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572656     DOI: 10.1016/0888-7543(92)90316-k

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  66 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggression.

Authors:  Stephen D Ginsberg; Shaoli Che; Audrey Hashim; Jiri Zavadil; Robert Cancro; Sang H Lee; Eva Petkova; Henry W Sershen; Jan Volavka
Journal:  Brain Struct Funct       Date:  2011-04-22       Impact factor: 3.270

Review 3.  The role of catechol-O-methyltransferase in the inactivation of catecholestrogen.

Authors:  C R Creveling
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

4.  Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.

Authors:  C Carlson; H Sirotkin; R Pandita; R Goldberg; J McKie; R Wadey; S R Patanjali; S M Weissman; K Anyane-Yeboa; D Warburton; P Scambler; R Shprintzen; R Kucherlapati; B E Morrow
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  No significant association between Catechol-O-methyl transferase (COMT) -287A/G gene polymorphism and Tourette's syndrome in family-based association study in Chinese Han population.

Authors:  Shiguo Liu; Mingji Yi; Fengguang Qi; Yuping Sun; Fengyuan Che; Xu Ma
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-10-19       Impact factor: 4.785

6.  Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.

Authors:  Y Ji; J Biernacka; K Snyder; M Drews; L L Pelleymounter; C Colby; L Wang; D A Mrazek; R M Weinshilboum
Journal:  Pharmacogenomics J       Date:  2010-09-28       Impact factor: 3.550

7.  Evaluation of COMT Gene rs4680 Polymorphism as a Risk Factor for Endometrial Cancer.

Authors:  Pradeep Kumar; Garima Singh; Vandana Rai
Journal:  Indian J Clin Biochem       Date:  2018-12-04

8.  Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults.

Authors:  W Retz; M Rösler; C Kissling; S Wiemann; R Hünnerkopf; A Coogan; J Thome; C Freitag
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

Review 9.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Impact of interacting functional variants in COMT on regional gray matter volume in human brain.

Authors:  Robyn Honea; Beth A Verchinski; Lukas Pezawas; Bhaskar S Kolachana; Joseph H Callicott; Venkata S Mattay; Daniel R Weinberger; Andreas Meyer-Lindenberg
Journal:  Neuroimage       Date:  2008-11-21       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.